These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23316664)

  • 21. [The characteristics of the status of the cardiovascular system in psoriasis].
    Aĭziatulov RF; Iukhymenko VV
    Lik Sprava; 1996; (5-6):23-7. PubMed ID: 9377393
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts.
    Volf EM; Levine DE; Michelon MA; Au SC; Patvardhan E; Dumont N; Loo DS; Kuvin J; Gottlieb AB
    J Drugs Dermatol; 2011 Aug; 10(8):900-1. PubMed ID: 21818512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases.
    Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB
    Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psoriasis as an independent risk factor for development of coronary artery disease].
    Papo D; Hein R; Ring J
    Dtsch Med Wochenschr; 2010 Sep; 135(36):1749-54. PubMed ID: 20812162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic plaque psoriasis.
    Luba KM; Stulberg DL
    Am Fam Physician; 2006 Feb; 73(4):636-44. PubMed ID: 16506705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis.
    Rosa DJ; Machado RF; Matias FA; Cedrim SD; Noronha FL; Gaburri D; Gamonal A
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):348-53. PubMed ID: 21545540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The heartbreak of psoriasis: a review of cardiovascular risk in patients with psoriasis.
    Benson MM; Frishman WH
    Cardiol Rev; 2015; 23(6):312-6. PubMed ID: 26440534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.
    Boehncke WH; Boehncke S; Tobin AM; Kirby B
    Exp Dermatol; 2011 Apr; 20(4):303-7. PubMed ID: 21410760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis and cardiovascular risk factors: a case-control study on inpatients comparing psoriasis to dermatitis.
    Shapiro J; Cohen AD; Weitzman D; Tal R; David M
    J Am Acad Dermatol; 2012 Feb; 66(2):252-8. PubMed ID: 21742411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Psoriasis and atherothrombotic disease].
    Ahlehoff O; Gislason GH; Skov L; Hansen PR
    Ugeskr Laeger; 2010 Jun; 172(26):1983-6. PubMed ID: 20654288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psoriasis and cardio-vascular disorders].
    Wojas-Pelc A; Rajzer L; Rajzer M
    Przegl Lek; 2002; 59(10):844-7. PubMed ID: 12632926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriasis: cardiovascular risk factors and other disease comorbidities.
    Wu Y; Mills D; Bala M
    J Drugs Dermatol; 2008 Apr; 7(4):373-7. PubMed ID: 18459519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.
    Cozzani E; Rosa GM; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of narrowband UVB as a monotherapy for the treatment of chronic plaque psoriasis.
    Al Robaee AA
    J Drugs Dermatol; 2010 Aug; 9(8):989-91. PubMed ID: 20684149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patients with psoriasis have an increased risk of cardiovascular diseases].
    Ahlehoff O; Gislason G; Lindhardsen J; Skov L; Hansen PR
    Ugeskr Laeger; 2012 May; 174(21):1450-2. PubMed ID: 22640784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of physical activity, cardiorespiratory fitness, and exercise training on markers of inflammation.
    Lavie CJ; Church TS; Milani RV; Earnest CP
    J Cardiopulm Rehabil Prev; 2011; 31(3):137-45. PubMed ID: 21427600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.